Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Outstanding (Weighted Average) (2020 - 2023)

Historic Shares Outstanding (Weighted Average) for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $82.3 million.

  • ADC Therapeutics' Shares Outstanding (Weighted Average) rose 483853805.88% to $82.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $82.3 million, marking a year-over-year increase of 483853805.88%. This contributed to the annual value of $80.5 million for FY2022, which is 476.74% up from last year.
  • Per ADC Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $82.3 million for Q3 2023, which was up 483853805.88% from $1310.0 recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Shares Outstanding (Weighted Average) peaked at $82.3 million during Q3 2023, and registered a low of $220.0 during Q1 2022.
  • Over the past 4 years, ADC Therapeutics' median Shares Outstanding (Weighted Average) value was $1660.0 (recorded in 2021), while the average stood at $17.1 million.
  • As far as peak fluctuations go, ADC Therapeutics' Shares Outstanding (Weighted Average) tumbled by 6716.42% in 2022, and later soared by 483853805.88% in 2023.
  • Over the past 4 years, ADC Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $3090.0 in 2020, then skyrocketed by 2485397.57% to $76.8 million in 2021, then rose by 4.77% to $80.5 million in 2022, then increased by 2.23% to $82.3 million in 2023.
  • Its Shares Outstanding (Weighted Average) stands at $82.3 million for Q3 2023, versus $1310.0 for Q2 2023 and $740.0 for Q1 2023.